SpectraCure presentations at investor meetings this fall

SpectraCure (http://www.spectcomracure.) will be presented at Småbolagsjakten Live, September 25th and at at Stora Aktiedagen, November 4th.

SpectraCure will be presented at Småbolagsjakten Live, September 25th 

Welcome to come and listen when the CEO of SpectraCure, Masoud Khayyami, holds a company presentation at the investor meeting Småbolagsjakten Live.
The event has attracted great interest and is already sold out. Do not despair if you haven’t got a seat – the event will be broadcast live in theFacebook group
Aktier – Småbolagsjakten on investerarbrevet.se. 

When?          September 25th, at 7.50 pm.

Where?         GT30, Bond, Grev Turegatan 30, Stockholm


SpectraCure at Stora Aktiedagen, November 4th 

A second chance to listen to Masoud Khayyami, CEO of SpectraCure, is given at Stora Aktiedagen in Gothenburg. The event will be streamed at aktiespararna.se.

Further details regarding Stora Aktiedagen will be shared as soon as the programme is fixed.

SpectraCure

For further information, contact:
SpectraCure AB publ, CEO, Masoud Khayyami, phone: +46(0) 70 815 21 90

Certified Adviser is G&W Fondkommission, e-mail: ca@gwkapital.se, phone: +46-(8)-503 000 50.

Release
Masoud Khayyami, VD SpectraCure AB

SpectraCure is developing the future systems for the treatment of internal solid cancer tumours. The goal of the proprietary and patented treatment system is to eliminate deep-seated cancer tumours and prolong the survival of cancer patients while maintaining their quality of life. When prostate cancer recurs, there are often no established treatment options other than lifelong hormone therapy, with its associated side effects. 

Facebook Linkedin Envelope